Prevalence of high-risk human papillomavirus infection and genotype distribution among Kazakhstani women with abnormal cervical cytology

References

• Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):1–7. doi: 10.1016/S2214-109X(19)30482-6.
   Web of Science ®Google Scholar
• Serrano B, Brotons M, Bosch FX, et al. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14–26. doi: 10.1016/j.bpobgyn.2017.08.006.
   PubMed Web of Science ®Google Scholar
• Bruni L, Albero G, Serrano B, et al. ICO/IARC information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in Kazakhstan. Summary Report 17 June; 2019 [cited 2023 Jun 25].
   Google Scholar
• Aimagambetova G, Azizan A. Epidemiology of HPV infection and HPV-Related cancers in Kazakhstan: a review. Asian Pac J Cancer Prev. 2018;19(5):1175–1180. doi: 10.22034/APJCP.2018.19.5.1175.
   PubMedGoogle Scholar
• Aimagambetova G, Chan CK, Ukybassova T, et al. Cervical cancer screening and prevention in Kazakhstan and Central Asia. J Med Screen. 2021;28(1):48–50. doi: 10.1177/0969141320902482.
   PubMed Web of Science ®Google Scholar
• Igissinov N, Igissinova G, Telmanova Z, et al. New trends of cervical cancer incidence in Kazakhstan. Asian Pac J Cancer Prev. 2021;22(4):1295–1304. doi: 10.31557/APJCP.2021.22.4.1295.
   PubMedGoogle Scholar
• Balmagambetova S, Gabutti G, Koyshybaev A, et al. Cervical screening in Western Kazakhstan: liquid-based cytology ‘cell scan’ versus azur-eosin staining. J Med Screen. 2020;27(2):90–95. doi: 10.1177/0969141319885409.
   PubMed Web of Science ®Google Scholar
• de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–670. doi: 10.1002/ijc.30716.
   PubMed Web of Science ®Google Scholar
• Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342–350. doi: 10.1038/nrc798.
   PubMed Web of Science ®Google Scholar
• Paavonen J. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias. Int J Infect Dis. 2007;11(Suppl. 2):S3–S9. doi: 10.1016/S1201-9712(07)60015-0.
   PubMed Web of Science ®Google Scholar
• Clifford G, Franceschi S, Diaz M, et al. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24(Suppl. 3):S3/26–34. doi: 10.1016/j.vaccine.2006.05.026.
   PubMedGoogle Scholar
• Akhatova A, Azizan A, Atageldiyeva K, et al. Prophylactic human papillomavirus vaccination: from the origin to the current state. Vaccines. 2022;10(11):1912. doi: 10.3390/vaccines10111912.
   Web of Science ®Google Scholar
• McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425–434. doi: 10.1016/S1470-2045(08)70103-7.
   PubMed Web of Science ®Google Scholar
• Gravitt PE, Rositch AF, Silver MI, et al. A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. J Infect Dis. 2013;207(2):272–280. doi: 10.1093/infdis/jis660.
   PubMed Web of Science ®Google Scholar
• Imankulova B, Babi A, Issa T, et al. Prevalence of precancerous cervical lesions among nonvaccinated Kazakhstani women: the National Tertiary Care Hospital Screening Data (2018). Healthcare. 2023;11(2):235. doi: 10.3390/healthcare11020235.
   Web of Science ®Google Scholar
• Vinodhini K, Shanmughapriya S, Das BC, et al. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012;285(3):771–777. doi: 10.1007/s00404-011-2155-8.
   PubMed Web of Science ®Google Scholar
• Niyazmetova L, Aimagambetova G, Stambekova N, et al. Application of molecular genotyping to determine prevalence of HPV strains in pap smears of Kazakhstan women. Int J Infect Dis. 2017;54:85–88. doi: 10.1016/j.ijid.2016.11.410.
   PubMed Web of Science ®Google Scholar
• Bekmukhambetov Y, Balmagambetova S, Jarkenov T, et al. Distribution of high risk human papillomavirus types in Western Kazakhstan – retrospective analysis of PCR data. Asian Pac J Cancer Prev. 2016;17(5):2667–2672.
   PubMedGoogle Scholar
• Aimagambetova G, Babi A, Issanov A, et al. The distribution and prevalence of high-risk HPV genotypes other than HPV-16 and HPV-18 among women attending gynecologists’ offices in Kazakhstan. Biology. 2021;10(8):794. doi: 10.3390/biology10080794.
   PubMedGoogle Scholar
• Babi A, Issa T, Issanov A, et al. Prevalence of high-risk human papillomavirus infection among Kazakhstani women attending gynecological outpatient clinics. Int J Infect Dis. 2021;109:8–16. doi: 10.1016/j.ijid.2021.06.006.
   PubMed Web of Science ®Google Scholar
• Aimagambetova G, Babi A, Issa T, et al. What factors are associated with attitudes towards HPV vaccination among Kazakhstani women? Exploratory analysis of cross-sectional survey data. Vaccines. 2022;10(5):824. doi: 10.3390/vaccines10050824.
   Web of Science ®Google Scholar
• Babi A, Issa T, Issanov A, et al. Knowledge and attitudes of mothers toward HPV vaccination: a cross-sectional study in Kazakhstan. Womens Health. 2023;19:17455057231172355. doi: 10.1177/17455057231172355.
   Web of Science ®Google Scholar
• Aimagambetova G, Azizan A. Human papillomavirus vaccination: past, present and future. Vaccines. 2022;10(9):1398. doi: 10.3390/vaccines10091398.
   Web of Science ®Google Scholar
• Nayar R, Wilbur DC, editors. The Bethesda system for reporting cervical cytology. Springer; 2015. doi: 10.1007/978-3-319-11074-5
   Google Scholar
• Cuschieri K, Fellner MD, Arroyo Mühr LS, et al. Quality assurance in human papillomavirus testing for primary cervical screening. Int J Gynecol Cancer. 2023;33(5):802–811. doi: 10.1136/ijgc-2022-004197.
   PubMed Web of Science ®Google Scholar
• Muderris T, Afsar I, Yıldız A, et al. HPV genotype distribution among women with normal and abnormal cervical cytology in Turkey. Rev Esp Quimioter. 2019;32(6):516–524.
   PubMed Web of Science ®Google Scholar
• Wang X, Huang X, Zhang Y. Involvement of human papillomaviruses in cervical cancer. Front Microbiol. 2018;9:2896. doi: 10.3389/fmicb.2018.02896.
   PubMed Web of Science ®Google Scholar
• Issa T, Babi A, Azizan A, et al. Factors associated with cervical cancer screening behaviour of women attending gynaecological clinics in Kazakhstan: a cross-sectional study. Womens Health. 2021;17:17455065211004135. doi: 10.1177/17455065211004135.
   Web of Science ®Google Scholar
• Finan RR, Chemaitelly H, Racoubian E, et al. Genetic diversity of human papillomavirus (HPV) as specified by the detection method, gender, and year of sampling: a retrospective cross-sectional study. Arch Gynecol Obstet. 2023;307(5):1469–1479. doi: 10.1007/s00404-022-06907-4.
   PubMed Web of Science ®Google Scholar
• Tsedenbal B, Yoshida T, Enkhbat B, et al. Human papillomavirus genotyping among women with cervical abnormalities in Ulaanbaatar, Mongolia. Int J Infect Dis. 2018;77:8–13. doi: 10.1016/j.ijid.2018.09.018.
   PubMed Web of Science ®Google Scholar
• Shipitsyna E, Zolotoverkhaya E, Kuevda D, et al. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia. Cancer Epidemiol. 2011;35(2):160–164. doi: 10.1016/j.canep.2010.08.010.
   PubMed Web of Science ®Google Scholar
• Beyazit F, Sılan F, Gencer M, et al. The prevalence of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology. Ginekol Pol. 2018;89(2):62–67. doi: 10.5603/GP.a2018.0011.
   PubMed Web of Science ®Google Scholar